Assignee
H LEE MOFFITT CANCER CT & RES
US·230 granted patents·257 pending applications·563 citations·filing 2001–2025
Top patents by PatentIndex Score
487 records- 0197US11976104B2TLR9 ligand trapH LEE MOFFITT CANCER CT & RES·Filed 2021·Granted May 7, 2024·6 cites·10 claims
- 0295US10322009B2Expandable intervertebral cageH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Jun 18, 2019·48 cites·16 claims
- 0394US10799367B2Bone fusion systemH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Oct 13, 2020·42 cites·33 claims
- 0494US10339653B2Systems, methods and devices for analyzing quantitative information obtained from radiological imagesH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Jul 2, 2019·26 cites·24 claims
- 0594US10016421B2Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccinationH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Jul 10, 2018·10 cites·14 claims
- 0694US9987258B2Histone deacetylase as a modulator of PDL1 expression and activityH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Jun 5, 2018·10 cites·5 claims
- 0794US9409858B2Selective histone deactylase 6 inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2013·Granted Aug 9, 2016·11 cites·22 claims
- 0893US10687876B2Bone fusion systemH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Jun 23, 2020·24 cites·46 claims
- 0992US10152796B2Methods and systems for performing segmentation and registration of images using neutrosophic similarity scoresH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Dec 11, 2018·43 cites·18 claims
- 1092US9751832B2Selective histone deactylase 6 inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2014·Granted Sep 5, 2017·11 cites·7 claims
- 1192US9721340B2Systems, methods and devices for analyzing quantitative information obtained from radiological imagesH LEE MOFFITT CANCER CT & RES·Filed 2014·Granted Aug 1, 2017·106 cites·20 claims
- 1290US11530182B2YAP1 inhibitors that target the interaction of YAP1 with Oct4H LEE MOFFITT CANCER CT & RES·Filed 2020·Granted Dec 20, 2022·2 cites·18 claims
- 1390US10336734B2Inhibitors of ACK1/TNK2 tyrosine kinaseH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Jul 2, 2019·7 cites·9 claims
- 1489US10697023B2Systems and methods for providing personalized radiation therapyH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Jun 30, 2020·4 cites·10 claims
- 1589US10314631B2Transdiscal screwH LEE MOFFITT CANCER CT & RES·Filed 2014·Granted Jun 11, 2019·34 cites·14 claims
- 1687US12156818B2Expandable inter vertebral cageH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted Dec 3, 2024·1 cites·24 claims
- 1787US10240208B2MicroRNA assay for detection and management of pancreatic cancer precursorsH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Mar 26, 2019·5 cites·10 claims
- 1887US10118942B2Toll-like receptor 2 ligands and methods of making and using thereofH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Nov 6, 2018·4 cites·12 claims
- 1987US2025129118A1Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 2086US11730726B2Dimeric immuno-modulatory compounds against cereblon-based mechanismsH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Aug 22, 2023·2 cites·14 claims
- 2186US11134997B2Bone fusion systenH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Oct 5, 2021·5 cites·20 claims
- 2286US10906874B2YAP1 inhibitors that target the interaction of YAP1 with OCT4H LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Feb 2, 2021·2 cites·19 claims
- 2386US10071094B2Protein phosphatase 2A inhibitors for treating myelodysplastic syndromesH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Sep 11, 2018·7 cites·19 claims
- 2485US11396554B2Bispecific antibody for cancer immunotherapyH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Jul 26, 2022·4 cites·8 claims
- 2585US11286306B2TLR9-binding chimeric antigen receptorsH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Mar 29, 2022·4 cites·17 claims
- 2685US11035006B2Colorectal cancer recurrence gene expression signatureH LEE MOFFITT CANCER CT & RES·Filed 2014·Granted Jun 15, 2021·3 cites·29 claims
- 2785US10526291B2Potent dual BRD4-kinase inhibitors as cancer therapeuticsH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Jan 7, 2020·2 cites·33 claims
- 2884US10792083B2Bone fusion systemH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Oct 6, 2020·4 cites·19 claims
- 2984US10434100B2Protein phosphatase 2A inhibitors for treating myelodysplastic syndromesH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Oct 8, 2019·5 cites·20 claims
- 3084US9820788B2Bone fusion systemH LEE MOFFITT CANCER CT & RES·Filed 2012·Granted Nov 21, 2017·16 cites·15 claims
- 3184US2025122579A1Microrna assay for detection and management of pancreatic cancer precursorsH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 3283US12551254B2Bone fusion systemH LEE MOFFITT CANCER CT & RES·Filed 2023·Granted Feb 17, 2026·0 cites·19 claims
- 3383US11479606B2Compositions and methods for targeting CD33-expressing cancersH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Oct 25, 2022·2 cites·11 claims
- 3483US10793595B2Toll-like receptor 2 ligands and methods of making and using thereofH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Oct 6, 2020·2 cites·12 claims
- 3583US10011635B2Cyclic peptide conjugates and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2014·Granted Jul 3, 2018·3 cites·9 claims
- 3682US10918638B2Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccinationH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Feb 16, 2021·1 cites·10 claims
- 3782US10565430B2Histology recognition to automatically score and quantify cancer grades and individual user digital whole histological imaging deviceH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Feb 18, 2020·4 cites·11 claims
- 3882US10449227B2Conjugates for immunotherapyH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Oct 22, 2019·2 cites·9 claims
- 3982US10041129B2Immune gene signatures in cancerH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Aug 7, 2018·3 cites·15 claims
- 4082US10007982B2Automated percentage of breast density measurements for full field digital mammographyH LEE MOFFITT CANCER CT & RES·Filed 2014·Granted Jun 26, 2018·9 cites·10 claims
- 4182US2023201191A1Platinum compounds that inhibit constitutive stat3 signaling and induce cell cycle arrest and apoptosis of malignant cellsH LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 4281US11584787B2Soluble CD33 for treating myelodysplastic syndromes (MDS)H LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Feb 21, 2023·1 cites·16 claims
- 4381US11434290B2Chimeric antigen receptors with enhanced NFκB signalingH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Sep 6, 2022·2 cites·18 claims
- 4481US10414810B2Double mutant survivin vaccineH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Sep 17, 2019·2 cites·10 claims
- 4581US2025143764A1Transdiscal screwH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 4680US12233054B2Dimeric immuno-modulatory compounds against cereblon-based mechanismsH LEE MOFFITT CANCER CT & RES·Filed 2023·Granted Feb 25, 2025·0 cites·13 claims
- 4780US12186404B2Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancerH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted Jan 7, 2025·0 cites·6 claims
- 4880US12065474B2Chimeric antigen receptors with mutated CD28 costimulatory domainsH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Aug 20, 2024·1 cites·10 claims
- 4980US12036273B2Compositions and methods for targeting CD99-expressing cancersH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Jul 16, 2024·1 cites·17 claims
- 5080US11525004B2Recombinant CD123-binding antibodiesH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Dec 13, 2022·2 cites·11 claims
Showing the top 50 of 487 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when H LEE MOFFITT CANCER CT & RES files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →